PGNY vs TNDM

PGNY exhibits exceptional fundamental health, highlighted by a perfect Piotroski F-Score of 9/9 and a negligible Debt/Equity ratio of 0.05. While the stock has suffered significant long-term price decay and currently faces bearish technical trends and insider selling, the valuation is highly attractive on a forward basis with a Forward P/E of 8.53. The company's consistent track record of earnings beats and strong earnings growth (20.6% YoY) suggests a disconnect between market sentiment and operational performance. The current price of $17.93 sits comfortably below the growth-based intrinsic value of $19.77 and well below analyst targets.

TNDM exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational deterioration. While analysts maintain a 'buy' rating with a target of $30.62, the company suffers from negative profit margins (-20.17%), a deeply negative ROE (-97.89%), and high leverage (Debt/Equity of 2.90). Despite a strong current ratio providing short-term liquidity, the lack of meaningful revenue growth (2.70%) and bearish insider sentiment suggest the current price is speculative rather than fundamentally supported.